<?xml version="1.0" ?>
<tei>
	<teiHeader>
		<fileDesc xml:id="55004227"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	<docTitle>
	<titlePart>Activation of MyoD-dependent transcription by cdk9/cyclin T2<lb/></titlePart>
	</docTitle>

	<byline>
	<docAuthor>Cristiano Simone<lb/> 1,2,3<lb/> , Peter Stiegler<lb/> 2<lb/> , Luigi Bagella<lb/> 1,2,4<lb/> , Bruna Pucci<lb/> 2<lb/> , Cristiana Bellan<lb/> 1,4<lb/> , Giulia De Falco<lb/> 1<lb/> , Antonio De Luca<lb/> 1,5<lb/> , Ginevra Guanti<lb/> 3<lb/> , Pier Lorenzo Puri<lb/> 6,7<lb/> and Antonio Giordano*<lb/> ,1,2<lb/></docAuthor>
	</byline>

	<byline>
	<affiliation>1 Sbarro Institute for Cancer Research and Molecular Medicine, Temple University,</affiliation>
	</byline>

	<address>Philadelphia, Pennsylvania, PA 19122 USA;<lb/></address>

	<byline>
	<affiliation>2<lb/> Department of Pathology, Anatomy and Cell Biology, Thomas Jeerson University,</affiliation>
	</byline>

	<address>Philadelphia, Pennsylvania, PA 19107 USA;<lb/></address>

	<byline>
	<affiliation>3<lb/> Department of Internal Medicine and Public Medicine, Division of Medical Genetics, University of Bari,</affiliation>
	</byline>

	<address>Bari 70124 Italy;<lb/></address>

	<byline>
	<affiliation>4 Institute of Pathologic Anatomy and Histology, University of Siena,</affiliation>
	</byline>

	<address>Siena 53100 Italy;<lb/></address>

	<byline>
	<affiliation>5<lb/> Institute of Topographical Anatomy,<lb/> School of Medicine, 2nd University of Naples,</affiliation>
	</byline>

	<address>Naples 80138 Italy;<lb/></address>

	<byline>
	<affiliation>6 Laboratory of Gene Expression,</affiliation>
	</byline>

	<address>Fondazione Andrea Cesalpino,<lb/></address>

	<byline>
	<affiliation>University of Romè</affiliation>
	</byline>

	<address>La Sapienza&apos;, 0061 Rome, Italy;<lb/></address>

	<byline>
	<affiliation>7<lb/> Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for<lb/> Biological Studies,</affiliation>
	</byline>

	<address>La Jolla, California, CA 92093, USA<lb/></address>

	<div type="abstract">Myogenic transcription is repressed in myoblasts by<lb/> serum-activated cyclin-dependent kinases, such as cdk2<lb/> and cdk4. Serum withdrawal promotes muscle-speci®c<lb/> gene expression at least in part by down-regulating the<lb/> activity of these cdks. Unlike the other cdks, cdk9 is not<lb/> serum-or cell cycle-regulated and is instead involved in the<lb/> regulation of transcriptional elongation by phosphorylat-<lb/>ing the carboxyl-terminal domain (CTD) of RNA<lb/> polymerase II. While ectopic expression of cdk2 together<lb/> with its regulatory subunits (cyclins E and A) inhibits<lb/> myogenic transcription, overproduction of cdk9 and its<lb/> associated cyclin (cyclin T2a) strengthens MyoD-depen-<lb/>dent transcription and stimulates myogenic dierentiation<lb/> in both MyoD-converted ®broblasts and C2C12 muscle<lb/> cells. Conversely, inhibition of cdk9 activity by a dominant<lb/> negative form (cdk9-dn) represses the myogenic program.<lb/> Cdk9, cyclinT2 and MyoD can be detected in a multimeric<lb/> complex in C2C12 cells, with the minimal cdk9-binding<lb/> region of MyoD mapping within 101 ± 161 aa of the<lb/> bHLH region. Finally, cdk9 can phosphorylate MyoD in<lb/> vitro, suggesting the possibility that cdk9/cycT2a regula-<lb/>tion of muscle dierentiation includes the direct enzymatic<lb/> activity of the kinase on MyoD.<lb/></div>

	<reference>Oncogene (2002) 21, 4137 ± 4148.</reference>

	<idno type="DOI">doi:10.1038/sj.onc.<lb/> 1205493<lb/></idno>

	<keyword>Keywords: cdk9; cyclins; MyoD; muscle dierentiation,<lb/> phosphorylation<lb/></keyword>

		</front>
	</text>
</tei>
